Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect

Hepatocellular carcinoma (HCC) is a tumor that exhibits glucometabolic reprogramming, with a high incidence and poor prognosis. Usually, HCC is not discovered until an advanced stage. Sorafenib is almost the only drug that is effective at treating advanced HCC, and promising metabolism-related thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Huining, Zhu, Xiaoyu, Lv, You, Jiao, Yan, Wang, Guixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381782/
https://www.ncbi.nlm.nih.gov/pubmed/32765096
http://dx.doi.org/10.2147/CMAR.S258196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381782/
https://www.ncbi.nlm.nih.gov/pubmed/32765096
http://dx.doi.org/10.2147/CMAR.S258196

Ejemplares similares